EXTEND is the third National Technology Transfer Hub launched by CDP Venture Capital SGR through its Technology Transfer Fund. Created in collaboration with Evotec, EXTEND represents a multidisciplinary and multi-actor platform that brings together: the main Universities and Research Centres specialised in the biotech sector, technical incubation and venture building partners with an international track record, leading pharmaceutical firms and dedicated venture capital funds, which together share the ambition of guaranteeing the competitive development of the sector and access to the market for the best initiatives.

The Hub’s purpose is to identify novel targets and therapeutic approaches to treat diseases through new start-ups’ creation. The name EXTEND refers to the ultimate objective of the biotech sector which is to improve and lengthen health conditions.

The initiative combines the respective strengths of:

  • Academic innovation in the life sciences, in particular in the biotechnologies, of the primary universities and research centres with a relevant research track record
  • CDP Venture Capital SGR S.p.A. – a venture capital firm which manages 13 active funds for a total asset under management of more than 3,8 billion euros.
  • Evotec – a drug discovery and development company with an international track record of academic collaborations across the globe and a growing portfolio of equity investments
  • Angelini Ventures – the corporate venture arm of Angelini Industries, that applies the know-how of the multi-business industrial group to create, support and invest in companies in digital health and life science